Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 6588239)

Published in J Natl Cancer Inst on July 01, 1984

Authors

R J Biggar, J Horm, J F Fraumeni, M H Greene, J J Goedert

Articles citing this

Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev (2003) 2.90

High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol (1999) 2.27

Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.64

Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer (2003) 1.60

Kaposi's sarcoma in England and Wales before the AIDS epidemic. Br J Cancer (1992) 1.48

High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands. Br J Cancer (1998) 1.45

Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer (1994) 1.38

Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic. Br J Cancer (1996) 0.99

Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study. Br J Cancer (1998) 0.99

Kaposi sarcoma involving the gastrointestinal tract. Gastroenterol Hepatol (N Y) (2010) 0.98

Epidemiological characteristics of Kaposi's sarcoma prior to the AIDS epidemic. Br J Cancer (1994) 0.92

Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998. Br J Cancer (2003) 0.81

A comparison of acquired immunodeficiency syndrome and Kaposi's sarcoma incidence rates, Atlanta, 1983-86. Am J Public Health (1989) 0.79

Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate. Br J Cancer (1998) 0.76

Endoscopic Appearance of Oropharyngeal and Upper GI Kaposi's Sarcoma in an Immunocompromised Patient. Case Rep Gastrointest Med (2017) 0.75

Articles by these authors

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68

Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science (1996) 15.63

Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17

Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57

Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11

Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30

Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54

A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39

Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science (1997) 5.91

Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98

The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81

Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68

Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62

Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59

Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) (1984) 4.39

Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33

Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04

HIV transmission through breastfeeding: a study in Malawi. JAMA (1999) 4.00

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Science (1998) 3.86

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77

Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72

Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66

Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63

Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60

Improving question wording in surveys of culturally diverse populations. Ann Epidemiol (1997) 3.53

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50

Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36

Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31

Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30

Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26

An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21

A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13

Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00

Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis (2001) 2.95

Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83

Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med (1997) 2.81

Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78

Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76

Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71

The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68

Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66

Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65

A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59

Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58

Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55

Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54

The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst (1998) 2.53

High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet (1991) 2.51

Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50

International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50

Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49

Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47

Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45

Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43

Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38

Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36

Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr (1990) 2.35

Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35

Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32

Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol (2001) 2.30

Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst (1969) 2.30

Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst (1989) 2.28

Trends in HIV incidence among young adults in the United States. JAMA (1998) 2.28

Cancer mortality among chemists. J Natl Cancer Inst (1969) 2.28

The AIDS problem in Africa. Lancet (1986) 2.25

Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24

Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24

Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24

Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med (1977) 2.20

Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19

A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst (1984) 2.17

Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst (1998) 2.13

Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet (2005) 2.13

Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13

Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12

Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12

Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst (1976) 2.11

Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer (1994) 2.09

Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06